hotspot -WSS

hotspot

author：Wikipedia 2025-10-03 00:06:56 - browse：91

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

Fresh off of the news that its drug Wegovy may not just help people lose weight, but could also lower cardiac risks, Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a small Canadian biotech with a new approach to weight loss.

Novo will spend up to $1 billion to buy Inversago Pharma, which is developing an oral obesity drug that targets the cannabinoid receptor CB1. It’s the second big obesity acquisition this year, following Eli Lilly’s move to purchase startup Versanis Bio.

Drugs like Wegovy are in a class called GLP-1 drugs, which mimic the effects of the glucagon-like peptide 1 hormone that help people feel full by targeting the hormone’s receptors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Readout LOUD: Venture capital, Gilead, and more M&A

hotspot

WSS

Medical schools are missing the mark on artificial intelligence

Russian court extends detention of American musician

Medicare Advantage plans can’t deny care with AI, CMS warns

California Joshua trees severely burned in massive wildfire

Surgery pushed Ben Carson to fame

Climate activists disrupt London Pride march to protest corporate sponsorship

entertainment

hotspot

focus

BioMarin wins approval for gene therapy to treat hemophilia A

AI gets buy

Jerome Adams on the need for new antivirals for Covid

Scientists find bacteria from stomach of ancient iceman

Medical records are filled with copy

Unique patient identifier: Experts argue the benefits, pitfalls

BioMarin wins approval for gene therapy to treat hemophilia A

California Joshua trees severely burned in massive wildfire

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Pediatricians' group reaffirms support for gender

leisure time

Does Medicare's free annual wellness visit do any good?

A single Democrat is willing to weaken Medicare negotiation power

Russian court extends detention of American musician

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Pediatricians' group reaffirms support for gender

Medicare Advantage plans can’t deny care with AI, CMS warns

Wikipedia

hotspot

hotspot

Wikipedia